In addition to the three NPVs, the FDA also announced the approval of an IND submission for DemeRx, which is investigating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results